Raleigh, North Carolina, United States Rex Health Ventures is the famous VC, which was founded in 2012. The leading representative office of defined VC is situated in the Raleigh. The company was established in North America in United States.
Among the various public portfolio startups of the fund, we may underline Phononic, Veran Medical Technologies, Gauss Surgical Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Medical, Biotechnology. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2016.
We also calculated 2 valuable employees in our database.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the Rex Health Ventures, startups are often financed by Promus Ventures, Prolog Ventures, Venrock. The meaningful sponsors for the fund in investment in the same round are Sands Capital Ventures, River Cities Capital Funds, New Leaf Venture Partners. In the next rounds fund is usually obtained by North Carolina Biotechnology Center, Versant Ventures, VentureSouth.
Related Funds
| Fund Name | Location |
| Beijing Ruibang Kaiyuan Investment | Beijing, Beijing, China |
| Beilun ZhongGang ZhuangShi | China, Ningbo, Zhejiang |
| Blue Planet Software | - |
| CCFO Investments | Afghanistan, Kabul, Kabul Province |
| CEED - Centre for Entrepreneurship Education and Development | Canada, Halifax, Nova Scotia |
| EEP Africa | Finland, Helsinki, Southern Finland |
| Elegant Themes | California, San Francisco, United States |
| Huamei International | China, Guangdong, Guangzhou |
| Mallinckrodt | Blanchardstown, Dublin, Ireland |
| Matrix Capital Management | Massachusetts, United States, Waltham |
| Mitsubishi Electric Affiliate | - |
| Olive Tree Ventures | Israel, Tel Aviv, Tel Aviv |
| Ritchie Capital Management | Cayman Islands, Grand Cayman |
| Shenzhen Huapengfei Modern Logistics | China, Guangdong, Shenzhen |
| Social Venture Circle | Durham, North Carolina, United States |
| Syndicat Technologies | - |
| Tabang Ziben | - |
| Tamar Ventures | Herzliya, Israel, Tel Aviv |
| TEV | Tengelmann Ventures | Essen, Germany, Nordrhein-Westfalen |
| Var Business Angels | France, Provence-Alpes-Cote d'Azur, Toulon |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Arrivo BioVentures LLC | $45M | 29 Nov 2023 | North Carolina, United States | ||
Vergent Bioscience | $21M | 04 Oct 2022 | Minneapolis, Minnesota, United States | ||
BioStable | 25 Feb 2020 | Austin, Texas, United States | |||
Bardy Diagnostics | $35M | 16 Apr 2019 | Seattle, Washington, United States | ||
Phynd Technologies | $8M | 29 Jan 2019 | Dallas, Texas, United States | ||
Gauss Surgical | $20M | 17 Oct 2018 | California, United States | ||
Emergo Therapeutics | $12M | 23 May 2018 | Durham, North Carolina, United States | ||
Target PharmaSolutions | 01 Dec 2016 | North Carolina, United States | |||
Kit Check | $20M | 20 Jun 2016 | Washington, District of Columbia, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Arrivo BioVentures LLC | $45M | 29 Nov 2023 | North Carolina, United States | ||
Vergent Bioscience | $21M | 04 Oct 2022 | Minneapolis, Minnesota, United States | ||
BioStable | 25 Feb 2020 | Austin, Texas, United States | |||
Bardy Diagnostics | $35M | 16 Apr 2019 | Seattle, Washington, United States | ||
Phynd Technologies | $8M | 29 Jan 2019 | Dallas, Texas, United States | ||
Gauss Surgical | $20M | 17 Oct 2018 | California, United States | ||
Emergo Therapeutics | $12M | 23 May 2018 | Durham, North Carolina, United States | ||
Target PharmaSolutions | 01 Dec 2016 | North Carolina, United States | |||
Kit Check | $20M | 20 Jun 2016 | Washington, District of Columbia, United States |
